What is Global Whole Transcriptomics Sequencing Market?
The Global Whole Transcriptomics Sequencing Market is a rapidly expanding field that focuses on the complete set of RNA sequences in a genome. This technology allows researchers to understand the functional elements of the genome and how they interact to influence cellular function. The market encompasses various technologies and applications, including RNA sequencing, microarray analysis, and PCR-based techniques. It's a comprehensive approach to studying the transcriptome, the complete set of RNA transcripts produced by the genome at any one time. This market is driven by the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing use of transcriptomics in biomarker discovery and validation.
PCR, Microarray, Sequencing in the Global Whole Transcriptomics Sequencing Market:
PCR, Microarray, and Sequencing are three key technologies in the Global Whole Transcriptomics Sequencing Market. PCR (Polymerase Chain Reaction) is a method widely used in molecular biology to make several copies of a specific DNA segment. It's a simple, highly sensitive technique that can amplify a single or few copies of a piece of DNA across several orders of magnitude, generating millions or more copies of a particular DNA sequence. Microarray, on the other hand, is a technology used to detect the expression of thousands of genes at once or to genotype multiple regions of a genome. Lastly, Sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases: adenine, guanine, cytosine, and thymine. These technologies are crucial in the field of transcriptomics as they provide a comprehensive view of the transcriptome, enabling researchers to study gene expression, identify gene functions, and understand the molecular basis of biological responses.
Pharmaceutical and Biotechnology, Academic Research and Government Institutes, Hospitals and Diagnostic Centers in the Global Whole Transcriptomics Sequencing Market:
The Global Whole Transcriptomics Sequencing Market finds its usage in various sectors such as Pharmaceutical and Biotechnology, Academic Research and Government Institutes, Hospitals and Diagnostic Centers. In the Pharmaceutical and Biotechnology sector, it is used for drug discovery and development, personalized medicine, and biomarker discovery. In Academic Research and Government Institutes, it is used for studying gene expression, identifying gene functions, and understanding the molecular basis of biological responses. In Hospitals and Diagnostic Centers, it is used for diagnosing diseases, predicting disease progression, and determining treatment strategies. The use of transcriptomics sequencing in these sectors is driven by the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing use of transcriptomics in biomarker discovery and validation.
Global Whole Transcriptomics Sequencing Market Outlook:
In terms of market outlook, the Global Whole Transcriptomics Sequencing Market is showing promising growth. In 2023, the market was valued at US$ 1645 million. However, it is projected to reach a staggering US$ 5894.3 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 20.0% during the forecast period from 2024 to 2030. This significant growth can be attributed to the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing use of transcriptomics in biomarker discovery and validation. The market's expansion is also driven by the rising prevalence of chronic diseases and the increasing need for early diagnosis and treatment.
| Report Metric | Details |
| Report Name | Whole Transcriptomics Sequencing Market |
| Accounted market size in 2023 | US$ 1645 million |
| Forecasted market size in 2030 | US$ 5894.3 million |
| CAGR | 20.0% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
